
With markets reacting to geopolitical tension, shifting rate expectations and mixed growth signals, some investors are looking beyond headlines to focus on what companies actually generate in cash. The Undervalued Stocks Based On Cash Flows screener does exactly that, highlighting stocks where SWS DCF valuation points to a meaningful gap between price and underlying cash potential. That can be especially useful when inflation, energy prices and policy uncertainty keep sentiment jumpy. In this article, you will see 3 of the stocks flagged by this cash flow focused tool, and how each might fit into a value oriented watchlist.
Overview: Chugai Pharmaceutical is a Japan based drug company that develops and sells prescription medicines globally, with a focus on complex biologic therapies across cancer, autoimmune and rare diseases, supported by a long standing partnership with Roche.
Operations: Chugai generates all of its ¥1,291,229 million revenue from pharmaceuticals, primarily across Japan and Switzerland.
Market Cap: ¥12.2t
Chugai Pharmaceutical is included in this cash flow focused list because it combines a broad biologics portfolio with high profitability. Recent half year results show revenue of ¥663,331 million and net income of ¥231,749 million, with net margins around 35%. At the same time, the company faces pressure from patent expiries, drug pricing rules and reliance on a few flagship products, so a key consideration for investors is whether its R&D pipeline and Roche partnership can sustain its earnings profile.
Chugai Pharmaceutical’s rich biologics margins can easily steal the spotlight, but the real story may be how those earnings compare with cash flow. Get the full picture with the DCF valuation analysis for Chugai Pharmaceutical
Overview: Furukawa Electric is a Japan based industrial company that supplies optical fiber, power cables, automotive wire harnesses and copper products that sit behind global telecom networks, energy grids, factories and vehicles.
Operations: Furukawa Electric generates around ¥1,370,000 million in revenue mainly from Electrical Electronics at ¥765,067 million and Infrastructure at ¥370,856 million, with smaller contributions from Functional Products and Services and Developments.
Market Cap: ¥2.4t
Furukawa Electric appears in a cash flow focused screen because it sits at the crossroads of data traffic, electrification and auto content, yet is priced below one estimate of fair value while carrying a richer P/E than many electrical peers. Recent results show ¥1,307,560 million in net sales and ¥72,514 million in net income. At the same time, debt coverage by operating cash flow, reliance on external funding and a volatile share price make the balance sheet and risk profile important to understand before relying on headline growth and new index inclusions.
Furukawa Electric’s richer P/E and index buzz may be masking what really matters: how its cash flows stack up against that valuation and funding needs, which the DCF valuation analysis for Furukawa Electric starts to unpack before the full story twists
Overview: Murata Manufacturing is a Japan based electronics company that supplies ceramic capacitors, sensors, batteries and communication modules that sit inside smartphones, cars, data centers, industrial equipment and connected devices around the world.
Operations: Murata Manufacturing generates around ¥1.93t in revenue, led by Components at ¥1,175,235 million and Devices and Modules at ¥655,981 million, with smaller contributions from Others and internal eliminations, and significant demand coming from Greater China, Asia and the United States.
Market Cap: ¥15.1t
Murata Manufacturing appears on a cash flow screen because it combines exposure to communication, automotive and IoT electronics with forecasts indicating earnings growth of around 24.3% a year and revenue growth faster than the broader Japanese market, while its P/E multiple remains well above industry levels. The company is rolling out new high reliability automotive capacitors and ultra low power sensors for wearables and IoT, while also returning cash through dividends and a sizeable buyback program. At the same time, the share price has been highly volatile, return on equity has been relatively low and all funding comes from higher risk external liabilities. For investors, the key question is whether the earnings trajectory and product depth are enough to justify that premium and volatility.
Murata Manufacturing’s earnings trajectory and premium P/E suggest the market may be missing something about its future cash power, and the analyst forecasts for Murata Manufacturing could reveal whether that confidence ignores a crucial twist
The three stocks in this article are just a starting point. The full Undervalued Stocks Based On Cash Flows tool has surfaced 55 more companies where price and cash flow potential tell equally compelling stories, all captured in the Undervalued Stocks Based On Cash Flows screener. Use Simply Wall St to identify and analyze the specific catalysts, cash flow traits and valuation gaps that matter most so you can focus on the highest conviction ideas from that list.
If Murata Manufacturing or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Some stocks move first while others get caught flat footed. Scan fresh ideas with real momentum under the radar for now, before the crowd catches up. Consider exploring these areas:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com